Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $4.0 million.

  • Organogenesis Holdings' Depreciation and Depletion rose 1285.71% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 1410.32%. This contributed to the annual value of $13.6 million for FY2024, which is 3038.86% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Depreciation and Depletion stood at $4.0 million, which was up 1285.71% from $3.7 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Depreciation and Depletion high stood at $4.0 million for Q3 2025, and its period low was $1.0 million during Q1 2021.
  • For the 5-year period, Organogenesis Holdings' Depreciation and Depletion averaged around $2.5 million, with its median value being $2.5 million (2023).
  • As far as peak fluctuations go, Organogenesis Holdings' Depreciation and Depletion plummeted by 2483.22% in 2022, and later surged by 10000.0% in 2023.
  • Over the past 5 years, Organogenesis Holdings' Depreciation and Depletion (Quarter) stood at $1.8 million in 2021, then fell by 14.51% to $1.5 million in 2022, then soared by 96.96% to $3.0 million in 2023, then rose by 21.23% to $3.6 million in 2024, then rose by 11.45% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $3.7 million for Q2 2025, and $3.4 million during Q1 2025.